News

As part of the agreement, the firms have announced the launch of Pamorelin in Singapore for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer. Under the

FDA stated that currently there is no sufficient evidence to support approval of QRxPharma’s pain drug Moxduo. According to FDA, clinical information showing a clear benefit over oxycodone

As per the deal, Abiogen granted Lee’s Pharm an exclusive license and right for registering, importing, marketing, distributing and selling Attila in the territory, for the two orphan/rare

Nuwiq, the first new generation FVIII replacement protein derived from a human cell line, is produced without animal derived products, and devoid of non human epitopes thought to

The company develops new treatments for Alzheimer’s disease (AD) based on technology licensed from Massachusetts General Hospital. The trial is for the company’s lead program, ALZT-OP1, a new

The drug belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors that provides a new approach to treat diabetes by increasing the loss

With the approval, Vectibix becomes the first and only biologic to provide a significant survival benefit as a first-line treatment with FOLFOX for patients with wild-type KRAS mCRC.

Plegridy is an investigational subcutaneous injectable therapy for RRMS, in which interferon beta-1a is pegylated to extend its half-life and prolong its exposure in the body. The positive

The three-period randomized, double-blind, three-period, parallel group, placebo-controlled Phase III trial showed that tofacitinib, as a 5mg or 10mg pill taken twice daily, met its two primary efficacy